These findings were corroborated by the Western blot analyses of both Capan-1 and PANC-1 cells (Figure 2F, 2K), indicating that TMBIM1 plays a role in regulating CCL2 and PD-L1 expression in pancreatic cancer cells. The gene discussed is CCL2; the disease is familial pancreatic carcinoma.